A nurse caring a patient on pancreatic enzyme replacement therapy should assess them for

JIPMER Nursing Officer-2017

Medical & Surgical Nursing

Medium

Appeared in: JIPMER Nursing Officer-2017

Explanation

Pancreatic Enzyme Replacement Therapy (PERT) is prescribed for exocrine pancreatic insufficiency, a condition causing malabsorption of nutrients.
The primary symptoms of malabsorption are significant weight loss and steatorrhea (fatty stools).
The goal of PERT is to provide the necessary digestive enzymes to improve nutrient absorption.
Therefore, weight gain is the most direct and crucial indicator that the therapy is therapeutically effective.
A reduction in the frequency and fat content of stools is also a sign of improvement.

Option B: Pancreatic enzymes act locally in the gastrointestinal tract to aid digestion and do not have systemic cardiovascular effects that would cause hypertension.
Option C: This medication does not affect the electrical conduction system of the heart and is not associated with causing arrhythmias.
Option D: While gastrointestinal irritation can be a side effect of PERT (especially if capsules are opened or chewed), it is not an indicator of therapeutic effectiveness. The question asks what to assess for to see if the treatment is working.

Clinical Relevance

Nursing practice connection: Use the key finding related to Assessment of therapeutic effectiveness for Pancreatic Enzyme Replacement Therapy (PERT) to guide bedside assessment, documentation, and the next nursing action.
The nurse's role in monitoring PERT effectiveness is crucial for managing patients with conditions like cystic fibrosis, chronic pancreatitis, or post-pancreatectomy, ensuring they achieve adequate nutrition and growth.
Patient education is a key nursing responsibility, including teaching the importance of taking enzymes with every meal and snack, and not crushing or chewing the capsules.
What if? If the patient continues to lose weight and have steatorrhea despite therapy, the nurse should assess for non-adherence (e.g., not taking enzymes with every meal), incorrect administration (e.g., crushing capsules), or an inadequate dosage, and then notify the healthcare provider for a potential adjustment.

How to Approach the Question

First, identify the core concept of the question: assessing the effectiveness of a specific medication, Pancreatic Enzyme Replacement Therapy (PERT).
Recall the primary purpose of PERT: to replace digestive enzymes that the pancreas is failing to produce.
Think about the underlying problem this therapy solves: malabsorption, which leads to symptoms like weight loss and fatty stools (steatorrhea).
Deduce that a successful therapy would reverse these symptoms. The most direct measure of reversing malnutrition and malabsorption is weight gain.
Evaluate the given options. 'Weight gain' directly aligns with the therapeutic goal. 'Hypertension' and 'Arrhythmias' are unrelated cardiovascular issues. 'GIT irritation' is a potential side effect, not a measure of success. This confirms that assessing for weight gain is the correct answer.

Concept Tested & Keywords

Concept Tested: Assessment of therapeutic effectiveness for Pancreatic Enzyme Replacement Therapy (PERT)
Stem keywords: pancreatic enzyme replacement therapy, assess
Lead-in keywords: should assess them for
Clinical cues: patient on pancreatic enzyme replacement therapy

Q_RLcO6QCY5xdz0YF8kz_w

E6 Nelson Textbook of Pediatrics(2024) — Volume 2 p. 208-210